Cargando…

Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements

AIM: The second Asia‐Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2020) gathered insights into the real‐world application in the Asia‐Pacific (APAC) region of consensus statements from the 3rd Advanced Prostate Cancer Consensus Conference (APCCC 2019). METHODS: The 4‐h our virtu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiong, Edmund, Murphy, Declan G., Buchan, Nicholas C., Chua, Melvin L. K., Hakim, Lukman, Hamid, Agus Rizal, Hong, Sung K., Horvath, Lisa G., Kanesvaran, Ravi, Khochikar, Makarand, Letran, Jason, Lojanapiwat, Bannakij, Malek, Rohan, Ng, Anthony C. F., Vinh, Nguyễn Tuấn, Pang, See‐Tong, Poon, Darren M. C., Ong, Teng Aik, Saad, Marniza, Schubach, Kathryn, Shiroki, Ryoichi, Türkeri, Levent, Williams, Scott, Wong, Alvin, Ye, Dingwei, Davis, Ian D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790439/ https://www.ncbi.nlm.nih.gov/pubmed/35134266 http://dx.doi.org/10.1111/ajco.13722

Ejemplares similares

Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
por: Saad, Marniza, et al.
Publicado: (2022)

Report of the third Asian Prostate Cancer study meeting
por: Lojanapiwat, Bannakij, et al.
Publicado: (2019)

Hormone refractory prostate cancer: Current understanding and future perspectives
por: Khochikar, Makarand
Publicado: (2007)

Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines
por: Khochikar, Makarand V.
Publicado: (2007)

Prostate cancer treatment does not increase the risk of cardiovascular events
por: Khochikar, Makarand V.
Publicado: (2007)

Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting
por: Kim, Choung-Soo, et al.
Publicado: (2017)

Is incidence of prostate cancer higher in patients with end stage renal disease?
por: Khochikar, Makarand V.
Publicado: (2007)

United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
por: Uemura, Hirotsugu, et al.
Publicado: (2020)

Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice
por: Lojanapiwat, Bannakij, et al.
Publicado: (2014)

Treatment of locally advanced and metastatic bladder cancer
por: Khochikar, Makarand V.
Publicado: (2008)

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
por: Lim, Jasmine, et al.
Publicado: (2020)

Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia
por: Ong, Teng Aik, et al.
Publicado: (2023)

Asia prostate cancer study (A-CaP Study) launch symposium
por: Akaza, Hideyuki, et al.
Publicado: (2016)

Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4–10 ng/mL and negative digital rectal examination
por: Sriplakich, Supon, et al.
Publicado: (2018)

The ideal puncture approach for PCNL: Fluoroscopy, ultrasound or endoscopy?
por: Lojanapiwat, Bannakij
Publicado: (2013)

Rationale for an early detection program for bladder cancer
por: Khochikar, Makarand V.
Publicado: (2011)

Neoadjuvant androgen suppression in patients treated with high-intensity focused ultrasound therapy
por: Khochikar, Makarand V.
Publicado: (2007)

The course of metastatic prostate cancer under treatment
por: Demir, Aslan, et al.
Publicado: (2014)

The efficacy of peritubal analgesic infiltration in postoperative pain following percutaneous nephrolithotomy – A prospective randomized controlled study
por: Lojanapiwat, Bannakij, et al.
Publicado: (2015)

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
por: Yekedüz, Emre, et al.
Publicado: (2021)

Management of advanced prostate cancer in a middle‐income country: real‐world consideration of the Advanced Prostate Cancer Consensus Conference 2017
por: Saad, Marniza, et al.
Publicado: (2019)

ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD(®)) in Asian men with prostate cancer
por: Malek, Rohan, et al.
Publicado: (2022)

Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand
por: Lojanapiwat, Bannakij, et al.
Publicado: (2017)

Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate Cancer
por: Tavukcu, Hasan Huseyin, et al.
Publicado: (2013)

Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries
por: Lim, Jasmine, et al.
Publicado: (2021)

Guy's Stone Score (GSS) Based on Intravenous Pyelogram (IVP) Findings Predicting Upper Pole Access Percutaneous Nephrolithotomy (PCNL) Outcomes
por: Lojanapiwat, Bannakij, et al.
Publicado: (2016)

Correlations between intraplan and postplan parameters in I-125 permanent prostate brachytherapy using loose seeds or linked seeds
por: Ito, Fumitaka, et al.
Publicado: (2022)

The impact of obesity towards prostate diseases
por: Parikesit, Dyandra, et al.
Publicado: (2016)

Controversies in the management of advanced prostate cancer
por: Tyrrell, C J
Publicado: (1999)

Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Turkish prostate cancer patients: a multicenter study of the Urooncology Association
por: Kızılay, Fuat, et al.
Publicado: (2020)

Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy
por: Armandari, Inna, et al.
Publicado: (2014)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis
por: Afriansyah, Andika, et al.
Publicado: (2018)

Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma
por: Mannatrizio, Domenico, et al.
Publicado: (2023)

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
por: Turco, Fabio, et al.
Publicado: (2022)

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
por: Gillessen, Silke, et al.
Publicado: (2023)

Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy
por: Liu, Wen, et al.
Publicado: (2020)

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
por: Gillessen, S., et al.
Publicado: (2015)

Advances in prostate cancer imaging
por: Tangel, Matthew R., et al.
Publicado: (2018)

The Suppression of Prolactin is required for the Treatment of Advanced Prostate Cancer
por: Costello, Leslie C
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_athtmd6geg1h1869nsgu0clvqs